Michael Gladstone is an associate in the life sciences group.
Prior to joining Atlas in 2012, Michael was a senior associate consultant in the life sciences practice at L.E.K. Consulting, where he focused on business development and corporate strategy for biopharma clients. While at L.E.K. Michael also served as head of client development for Inspire, a volunteer consulting firm staffed by junior consultants at L.E.K., Bain & Company, Parthenon, and Monitor Group. He led, designed, and organized teams of consultants for strategy projects for six non-profit organizations in the greater Boston area.
Prior to that, Michael was a Massachusetts Life Sciences Center Fellow at Eutropics, a Dana Farber Cancer Institute spin out, where he helped develop BH3 domain focused therapeutics and companion diagnostics for multiple myeloma and other malignancies. Previously, Michael worked in the viral pathogenesis department of Beth Israel Deaconess Medical Center where he conducted research on cellular HIV vaccines with Harvard Medical School Professor Norman Letvin. His research focused on elucidating the role of interleukin-21 on the cellular immune response to viral antigens.
Michael received a BS in biochemical sciences with highest honors from Harvard College, where he graduated magna cum laude and was awarded the Harvard College Scholarship. While at Harvard, he received a Herchel Smith Undergraduate Fellowship among other grants for his undergraduate research.
Michael is actively involved with National Tay-Sachs and Allied Diseases, a national organization focused on funding research, promoting awareness, and supporting families affected by Tay-Sachs and related genetic diseases. He is an avid basketball player and welcomes invitations to pick-up games in the Boston and Cambridge areas.